Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 3
2014 4
2015 5
2016 3
2017 1
2020 2
2021 2
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
Kálmán-Szabó I, Szabó JP, Arató V, Dénes N, Opposits G, Jószai I, Kertész I, Képes Z, Fekete A, Szikra D, Hajdu I, Trencsényi G. Kálmán-Szabó I, et al. Among authors: opposits g. Int J Mol Sci. 2022 Sep 2;23(17):10061. doi: 10.3390/ijms231710061. Int J Mol Sci. 2022. PMID: 36077458 Free PMC article.
In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.
Szabó JP, Csige K, Kálmán-Szabó I, Arató V, Opposits G, Jószai I, Kertész I, Képes Z, Méhes G, Fenyvesi F, Hajdu I, Trencsényi G. Szabó JP, et al. Among authors: opposits g. Int J Pharm. 2023 Jan 5;630:122462. doi: 10.1016/j.ijpharm.2022.122462. Epub 2022 Nov 30. Int J Pharm. 2023. PMID: 36462739 Free article.
In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Csige K, Szabó JP, Kálmán-Szabó I, Dénes NS, Szikra D, Képes Z, Opposits G, Méhes G, Kertész I, Fenyvesi F, Trencsényi G, Hajdu I. Csige K, et al. Among authors: opposits g. Int J Pharm. 2022 Sep 25;625:122132. doi: 10.1016/j.ijpharm.2022.122132. Epub 2022 Aug 24. Int J Pharm. 2022. PMID: 36028082 Free article.
27 results